Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.

Slides:



Advertisements
Similar presentations
or more simply.. -asthma is a condition of paroxysmal reversible airway obstruction which is characterised by : Airflow limitation ( reversible) Airway.
Advertisements

นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
2008 Guidelines 2.4 DIAGNOSIS IN ADULTS (1) -based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative.
Take a Deep Breath Asthma in Children Michael W. Peterson, M.D. Professor and Chief of Medicine UCSF Fresno.
Asthma What is Asthma ? V1.0 1997 Merck & ..
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
Long-term Controller Asthma Medications
Ibrahim Tawhari. Prepared by:. Scernario:  Khalid 14 years old come to the clinic c/o shortness of breath for one day duration.  He is a known asthmatic.
22/06/2011.  Asthma – an introduction (Vanessa)  Diagnosis and management of chronic asthma in line with current BTS guidelines (Dr Lowery)  3 x Case.
Chronic Obstructive Pulmonary Disease and Asthma: All That Wheezes? Clifford Courville, MD Pulmonary, Allergy, and Critical Care.
1 British Guideline on the Management of Asthma BTS/SIGN British Guideline on the Management of Asthma, May 2008 Introduction Diagnosis Non-pharmacological.
Bronchial asthma L de Man Dept of Physiotherapy UFS 2012.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 76 Drugs for Asthma.
Lisa Nave Nursing Platt College. Asthma is a chronic inflammatory disease of the lungs characterized by narrowing of the airways in the lungs causing.
Immunology of Asthma Immunology Unit Department of Pathology King Saud University.
Asthma Management Pathophysiology and Management University of Utah Center for Emergency Programs and The Utah Asthma Program.
Diagnosing asthma History & Physical examination Measurements of lung function – Spirometry – Peak expiratory flow Measurements of airway hyperresponsiveness.
Case No. 12 SH, 25 years old with a history of asthma since childhood presented to the OPD clinic with complaints of worsening dyspnea and wheezing. He.
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
Management of patients with allergic disorders. ASTHMA MANAGEMENT.
 Definition  Asthma is a chronic inflammatory disorder of the lung airways, characterised by reversible airway obstruction, airway hyper-responsiveness,
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Assessing Control & Adjusting Therapy in Youths > 12 Years of Age & Adults *ACQ values of 0.76–1.4 are indeterminate regarding well-controlled asthma.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
ASTHMA and the updated GINA Global initiative for asthma 2006 R. Louis Department of Pneumology CHU Sart-Tilman Liege.
What would be the most usual abnormal PE finding among asthma suspects? A. Wheezing on auscultation B. Wheezing only on forcible exhalation C. Absence.
Corticosteroid Therapy in Asthma Attaran D, MD,Pulmonologist, Associate professor, Mashhad University of Medical Sciences Attaran D, MD,Pulmonologist,
Asthma Asthma and Reactive Airway Disease Definition of asthma : Inflammatory disorder of small airways characterized by periodic attacks of wheezing,
Assessing Risk (Future) Domain – Of adverse events in the future, especially of exacerbations and of progressive, irreversible loss of pulmonary function—is.
Asthma Diagnosis: Anatomy and Pathophysiology of Asthma Karen Meyerson, MSN, RN, FNP-C, AE-C Asthma Network of West Michigan April 21, 2009 Acknowledgements:
Component 1: Measures of Assessment and Monitoring n Two aspects: –Initial assessment and diagnosis of asthma –Periodic assessment and monitoring.
Component 4 Medications.
Chronic Obstructive Pulmonary Disease
Asthma A Presentation on Asthma Management and Prevention.
ASTHMA UPDATE Chad Fowler, M.D. 10/27/04. Asthma: Why do we care? It’s common: Affects million persons in U.S. Most common chronic disease of childhood:
Asthma A Presentation on Asthma Management and Prevention.
Asthma Stephanie McAdams. Outline Background Causes Symptoms Treatments Conclusion Work Cited.
EXTRINSIC ASTHMA / ATOPIC Asthma can be characterized by recurrent dyspnea with airway inflammation and wheezing due to spasmodic constriction of the bronchi.
ASTHMA. Definition Chronic inflammation is associated with airway hyper-responsiveness that leads to recurrent episodes of wheezing, breathlessness, chest.
Drugs affecting the respiratory system. Main disorders of the respiratory system are 1.Bronchial asthma. 2.Chronic obstructive pulmonary disease (COPD).
Prof.Dr. Muhi K. Aljanabi MRCPCH; DCH; FICMS Consultant Pediatric Pulmonologist.
ASTHMA MANAGEMENT AND PREVENTION PREFACE Asthma affects an estimated 300 million individuals worldwide. Serious global health problem affecting all age.
Asthma Lynn Helliwell. Key Facts More than five million people in the UK are being treated for asthma More than five million people in the UK are being.
بسم الله الرحمن الرحيم وَإِذَا مَرِضْتُ فَهُوَ يَشْفِينِ صدق الله العظيم الشعراء 80.
An overview of Bronchial Asthma by Prof Nadeem Rizvi F.R.C.P. U.K Head of Chest Medicine Jinnah Postgraduate Medical Centre Karachi.
Pharmacologic Treatment Of Asthma 1 د. ميريانا البيضة.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Asthma 1 د. ميريانا البيضة. DIAGNOSIS 2 3 Definition of asthma.
ASTHMA Definition: Asthma is a chronic lung disease due to inflammation of the airways resulted into airway obstruction. The obstruction is reversible.
Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health – Dr Mazen.
Asthma ( Part 1 ) Dr.kassim.M.sultan F.R.C.P. Objectives: 1-Define asthma 2-Identify its aggravating factors 3-Describe its clinical features 4-Illustrate.
Asthma. What is Asthma?  According to the American Academy of Allergy Asthma & Immunology, asthma is a chronic disease involving the airways in the lungs,
Department of Pharmacology
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Respiratory Medications.
Asthma Review of Pathophysiology and Treatment. n definition of asthma –Asthma is a chronic inflammatory disorder of the airways in which many cells &
Respiratory Health Asthma and COPD. Definition of asthma 2 Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation.
Asthma Dr. Tseng, Chung-Chia. Defintiation Recurrent airflow obstructive pathology, remission by nature,recovery by therapy. Recurrent airflow obstructive.
Bronchial Asthma Definition Patho-physiology Diagnosis Management.
Eileen G. Holland, Pharm.D., BCPS Associate Professor
Asthma guidelines and treatment
Respiratory disorders
Asthma ( Part 2 ) Dr.kassim.M.sultan F.R.C.P.
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
Asthma Presented by Qassim j. odaa Master M.S.N..
Monitoring asthma in primary care
Renmin Hospital, Wuhan University Ding Xuhong (丁续红)
Asthma Allison Ormond, RN Pamlico County Primary School.
Respiratory disorders
ASTHMA Dr. Saviour K. Assoah (Medicine Dept). OUTLINE Definition Epidemiology Risks / precipitating factors Symptoms and signs Pathophysiology Types of.
Presentation transcript:

Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management

Asthma prevalence in Saudi Arabia  Children and Adolescents: 20 %  Adults : 10 %

Pathology of Asthma Inflammation Airway Hyper-responsivenessAirway Obstruction Symptoms of Asthma

Source: Peter J. Barnes, MD Mechanisms: Asthma Inflammation

During an asthma attack…

Sep-15 Asthma Microscopic Pathology Obstructed Inflammed Bronchi

Before 10 Minutes After Allergen Challenge Bronchoconstriction

Sep-15 Thick bronchi with Mucous plugs

Pathophysiology

Source: Peter J. Barnes, MD Asthma Inflammation: Cells and Mediators

ALLERGIC TRIGGERS

Triggers of Asthma (Irritants)  Infections  Chemicals  Diet/Medications  Strong Emotions  Exercise  Cold temperature  Exposure to smoke

Chronic inflammation Structural changes Acute inflammation TIMETIME Barnes PJ. Clin Exp Allergy “Real Life” Variability in Asthma symptoms subclinical

diagnosis is obvious

DIAGNOSIS OF ASTHMA  History and patterns of symptoms  Physical examination  Measurements of lung function

Bronchial Asthma Asthma is diagnosed clinically by history and P/E In case of doubt : - Spirometry - Methacholine challenge test

History  Tightness of the chest, cough & expectoration, wheeze  Comes in episodes, (recurrent )  With exposure to allergens and irritants  History of asthma attacks  Relieve using salbutamol  Allergy in skin, eyes, nose  Family history of asthma or allergy

Physical Examination  Wheeze /Rhonchi (no crackles)  Tachypnea (signs of allergy of skin, nose, eyes)  Remember Absence of symptoms at the time of examination does not exclude the diagnosis of asthma

Peak Flow Meter

Managing Asthma: Peak Expiratory Flow (PEF) Meters Allows the patient to assess the status of his or her asthma

What Types of Spirometers Are Available? SpirotelSensaireSatellite RenaissanceKoKoVitalograph 2120

Spirometry: Obstructive Disease Volume, liters Time, seconds FVC = 3.2L 94 % FEV 1 = 1.8L 66 % FEV 1 /FVC = 56% Normal Obstructive

What is Asthma ?  A chronic inflammatory disorder of the airway with Infiltration of mast cells, eosinophils and lymphocytes in response to allergens  Airway hyper-responsiveness ( twitchy airways)  Recurrent episodes of wheezing, coughing and shortness of breath  Variable and often reversible airflow limitation (airway obstruction )

 ICS = inhaled cortico-steroids budesonide, fluticasone, beclomethasone, ciclosenide, mometasone  B 2 Agonists : ( stimulants) Short acting : SABA salbutamol Long Acing : LABA: Rapid acting formeterol Non- Rapid acting salmeterol

 budesonide = Pulmicort  fluticasone = Flixotide  Ciclosenide = Alvesco

Combinations: Symbicort : budesonide + formoterol Seretide: fluticasone + salmeterol Foster: beclomethasone + formeterol

Anti-cholinergic drugs: Ipratropium (Atrovent) inhaler, solution for nebulizer Tiotropium (Spiriva) inhaler

Reliever/ Rescue Salbutamol Bronchodilator (beta 2 agonist)  Quickly relieves symptoms (within 2-3 minutes)  Not for regular use

 Anti-inflammatory  Takes time to act (1-3 hours)  Long-term effect (12-24 hours)  Only for regular use (whether well or not well) Preventer/ Controller

Controller Drugs  Inhaled steroids  Leukotriene modifiers (montelukast)  Anti-IgE (omalizumab =Xolair )  Systemic steroids

Adults Patients with Asthma

Rules of Two  Use of a quick-relief inhaler more than: 2 times per week  Awaken at night due to asthma symptoms more than: 2 times per month  Consumes a quick-relief inhaler more than: 2 times per year Need controller medication

Poor Asthma Control why ? Before increasing medications, check:  Inhaler technique  Adherence to prescribed regimen  Environmental changes  Also consider alternative diagnoses

Why inhalation therapy? Oral Slow onset of action Large dosage used Greater side effects Not useful in acute symptoms Inhaled Rapid onset of action Less amount of drug used Better tolerated Very effective

summary  Asthma can be controlled but not cured  It can present in at any age.  It produces recurrent attacks of symptoms of SOB, cough with or without wheeze  Between attacks patients with asthma lead normal lives  In most cases there is some history of allergy in the family.  Understanding the disease, learning the technique and compliance with medications is the key for good control of asthma